Table 1 Demographic, behavioral, and health profile of mothers of HIV-exposed children who were lost to follow-up notified to SINAN, in Porto Alegre, according to the outcome lost to follow-up, 2000 – 2017
| Â | Â | Lost to follow-up | Â | |
|---|---|---|---|---|
Characteristics | Total (%)a | Yes (%)a | No (%)a | p valueb |
6,836 | 1,763 (25.8) | 5,073 (74.2) | ||
Age range |  |  |  |  < 0.001 |
  Up to 22 | 1,952 (28,6) | 574 (29.4)1 | 1,378 (70.6) |  |
  23—26 | 1,549 (22.7) | 409 (26.4) | 1140 (73.6) |  |
  27—31 | 1,691 (24.8) | 398 (23.5) | 1293 (76.5) |  |
  32 or more | 1,640 (24) | 383 (23.3) | 1258 (76.7) |  |
Race/Color | Â | Â | Â | 0.001 |
  White | 3,798 (57.4) | 917 (24.1) | 2,881 (75.9) |  |
  Black or mixed | 2,821 (42.6) | 782 (27.7)2 | 2,039 (72.3) |  |
Schooling |  |  |  |  < 0.001 |
  Up to three years | 858 (13.9) | 286 (33.3)3 | 572 (66.7) |  |
  Between four and seven years | 3,062 (49.7) | 796 (26) | 2,266 (74) |  |
  Eight years or more | 2,244 (36.4) | 511 (22.8) | 1,733 (77.2) |  |
Partner with HIV | Â | Â | Â | 0.149 |
  Yes | 3,148 (73.3) | 790 (25.1) | 2,358 (74.9) |  |
  No | 1,148 (26.7) | 263 (22.9) | 885 (77.1) |  |
Intravenous drug use | Â | Â | Â | 0.003 |
  Yes | 500 (8.4) | 154 (30.8)4 | 346 (69.2) |  |
  No | 5,486 (91.6) | 1,347 (24.6) | 4,139 (75.4) |  |
HIV diagnosis |  |  |  |  < 0.001 |
  During prenatal care or at delivery | 4,045 (72) | 970 (24) | 3.075 (76) |  |
  Before prenatal care | 1,575 (28) | 546 (34.7)5 | 1,029 (65.3) |  |